Bob Lowenberg

26PUBLICATIONS
182CO-AUTHORS
Medical mycologyPredictive and prognostic markersGene and molecular therapyMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Feb 24, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Jan 13, 2026
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities.

Emma L Boertjes, Tim Grob, Adil Al Hinai

|Jul 17, 2025
Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia.

Emma L Boertjes, Christian M Vonk, François G Kavelaars

|May 22, 2025
A revised prognostic model for patients with acute myeloid leukemia and first relapse.

Niek G van der Maas, Dimitri Breems, Clara P W Klerk

|Dec 18, 2024
Double mutant DNMT3A AML: a unique subtype experiencing increased DNA damage and poor prognosis.

Emma L Boertjes, Sanne Massaar, Annelieke Zeilemaker

Pageof 5